Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

InheRET: A Software-as-a-Service (SaaS) Solution to Identifying Patients at Increased Risk for Hereditary Disease

NCT04510896 is registered in ClinicalTrials.gov with InheRET, Inc as lead sponsor.

NCT NCT04510896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
InheRET: A Software-as-a-Service (SaaS) Solution to Identifying Patients at Increased Risk for Hereditary Disease
Lead sponsor
InheRET, Inc
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2020
Completion date
August 31, 2022
Enrollment
2,232 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary cancer-predisposing syndrome